See today's BioWorld MedTech
To read the full story, subscribe or sign in.

FDA’s AI PCCP final guidance relaxes indication for use restrictions

Dec. 9, 2024
By Mark McCarty
The FDA’s final guidance for predetermined change control plans (PCCPs) for AI products contains a number of editorial changes, some more significant than others.
BioWorld BioWorld MedTech Regulatory Artificial intelligence Digital health U.S.